About Contact Us Careers

Ataxia Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3435
Published Date: Aug 27, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Ataxia Treatment Landscape

CRISPR Therapeutics AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Capsida Biotherapeutics, Inc.
Larimar Therapeutics, Inc.
Healx
Intellia Therapeutics, Inc.
Editas Medicine, Inc.
bluebird bio, Inc.
AAVLife SAS
Cellectis SA
Bio-Techne Corporation

Browse Key Market Insights with Data Illustration:

Ataxia Treatment Market Size & Share, Growth Forecast 2036

In the News

April 7, 2021- Healx launched a partnership with Ataxia UK, the leading charity in the United Kingdom for people suffering from ataxia, and FARA, a non-profit organization in the United States, to find treatments for rare neurodegenerative conditions, including ataxia.

Author Credits: Radhika Pawar

Report ID: 3435
Published Date: Aug 27, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Ataxia Treatment Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2024-2036.

The market growth is driven by increasing prevalence of ataxia around the world and growing number of incidences of autoimmune diseases.

Asia Pacific is expected to hold largest revenue share by 2036, on the back of increase in patient pool with genetic strains of ataxia, rising levels of awareness associated with the disease, and government initiatives to curb neurodegenerative disorders.

The major players in the market are CRISPR Therapeutics AG, Capsida Biotherapeutics, Inc., Larimar Therapeutics, Inc., Healx, and others.

Inquiry Before Buying Request Free Sample